Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
Jehoshaphat Research published a report on May 21, 2024, alleging, among other things, that Toro “has borrowed revenues and earnings from the future by selling excessive product into its dealer channel” and that the Company “set up a cliff” in its near-term operating cash flows worth $400 million or more.
Following this news, Toro’s stock price dropped over 3% the same day.
Ticker Symbol | Company Name | Join Deadline | Join |
---|---|---|---|
APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
NVO | Novo Nordisk A/S | March 25, 2025 | Join |
GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
NEM | Newmont Corporation | April 01, 2025 | Join |
GSK | GSK plc | April 07, 2025 | Join |
NTLA | Intellia Therapeutics, Inc. | April 14, 2025 | Join |
MRK | Merck & Co., Inc. | April 14, 2025 | Join |